Compare Enveric Biosciences Inc (ENVB) vs Standard Lithium Ltd (SLI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Standard Lithium Ltd — how do they compare? Enveric Biosciences Inc trades at $1.39 (market cap $5.32M), while Standard Lithium Ltd trades at $2.16 (market cap $551.38M). The key difference: Standard Lithium Ltd is far larger — about 103.6× Enveric Biosciences Inc's market cap. Which is the better fit depends on your goals.
| ENVB | SLI | |
|---|---|---|
Market Cap | $5.32M | $551.38M |
Sector | Health | Basic Materials |
52-Week High | $17.40 | $5.65 |
52-Week Low | $1.28 | $2.29 |
Enterprise Value | $408.82K | $410.57M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.
Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.
SLI trades at $2.22, down 3.9% in the last 24 hours, with a bearish technical signal from moving averages but bullish oscillators. The company reported a net loss of $48.40 million for 2025, with negative ROE and ROA, though it secured a $225 million DOE grant and is progressing toward a final investment decision for its Arkansas lithium project. Analyst consensus is unanimously bullish with 3 buy ratings.
The outlook hinges on successful project execution and lithium market dynamics, offering growth potential but carrying significant operational and financial risks due to current losses and high cash burn. Investors should weigh the strong analyst support against fundamental weaknesses and project timeline uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Standard Lithium Ltd
Standard Lithium Ltd. is a company focused on the development of lithium projects in North America, with a primary focus on extracting lithium from brine resources. Their flagship projects aim to utilize proprietary, advanced direct lithium extraction (DLE) technologies to produce high-purity lithium compounds in an environmentally responsible manner. The company seeks to become a key domestic supplier to the growing electric vehicle and battery storage markets.
Read more on SLI →
